SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: el vez who wrote (77286)2/20/2000 9:25:00 PM
From: el vez  Read Replies (1) of 108040
 
Re: previous post "FROM 2/19 Marketwatch -- Even languishing CytoTherapeutics (CTII: news, msgs), its stock stuck in
the mud for years, is enjoying good days. The company's StemCell, a
wholly-owned subsidiary, recently said it isolated a human brain stem cell for
the first time.The breakthrough could pave the way for techniques that repair
diseased or damaged brain tissue. The Nasdaq stock, as low as 3 a month
ago, was selling Friday morning for 8 1/2, up 29 percent for the day."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News